The implications of regulatory guidelines on allergen vial mixing for the practicing otolaryngologist

Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 4, 2007, Pages 658.e1-658.e4

  Lin, Sandra Y ^a   Houser, Steven M ^b   Rodriguez, Hector P ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

^c Columbia University School of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR SAMPLING; ALLERGENICITY; ARTICLE; AWARENESS; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; MEDICATION ERROR; OTORHINOLARYNGOLOGY; STANDARD;

EID: 34047106660     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2006.11.021     Document Type: Article

References (5)

1. Kohn L.T., Corrigan J.M., and Donaldson M.S. To err is human: building a safer health system (1999), Institute of Medicine, National Academy Press, Washington, DC
2. U.S. Pharmacopoeial Convention, Inc. U.S. Pharmacopeia 28. Chapter 797 pharmaceutical compounding-sterile preparations (2004), U.S. Pharmacopoeial Convention, Inc, Rockville, MD 2461-2477
3. Joint Commissions Perspectives 6 (2006) 5
4. Lockey R. Adverse reactions associated with skin testing and immunotherapy. Allergy Proc 16 (1995) 292-296
5. Kastango E.S. Quality-control analytical methods: USP chapter 797 compounded sterile preparations sterility requirements and their relationship to beyond-use dating. Int J Pharm Compd 8 (2004) 393-397